Parexel Exec On How CROs Should Prepare For Biosimilar Pathway, AI-Led Changes

 
• By Vibha Ravi
  
Parexel's India Head Sanjay Vyas Talks About Biosimilar Pathways, RWE and AI
Parexel's India Head Sanjay Vyas Talks About Biosimilar Pathways, RWE and AI (s STE StephanieEWENS Stephan/Stephanie Ewens Photography)

More from Review Pathways

More from Pathways & Standards